Chemclin Diagnostics Co. Ltd. A Capital Reinvestment Ratio
Chemclin Diagnostics Co. Ltd. A capital reinvestment ratio. Chemclin Diagnostics Co. Ltd. A (688468) has a Capital Reinvestment Ratio of 0.27x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥34.41 Million) in capital expenditures (CN¥9.16 Million). See 688468 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Chemclin Diagnostics Co. Ltd. A (2017–2025)
Capital reinvestment ratio of Chemclin Diagnostics Co. Ltd. A from 2017 to 2025. This chart tracks Chemclin Diagnostics Co. Ltd. A's Capital Reinvestment Ratio across 9 annual periods. See 688468 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Chemclin Diagnostics Co. Ltd. A Capital Reinvestment Ratio by Year (2017–2025)
Chemclin Diagnostics Co. Ltd. A capital reinvestment ratio by year from 2017 to 2025. For the full cash flow conversion analysis, see Chemclin Diagnostics Co. Ltd. A cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.74x | CN¥93.90 Million | CN¥69.88 Million | ▲ +16.3% |
| 2024 | 0.64x | CN¥167.95 Million | CN¥107.49 Million | ▼ -63.2% |
| 2023 | 1.74x | CN¥173.05 Million | CN¥301.37 Million | ▲ +240.0% |
| 2022 | 0.51x | CN¥244.56 Million | CN¥125.28 Million | ▲ +33.4% |
| 2021 | 0.38x | CN¥188.86 Million | CN¥72.55 Million | ▼ -29.9% |
| 2020 | 0.55x | CN¥151.95 Million | CN¥83.31 Million | ▲ +99.8% |
| 2019 | 0.27x | CN¥201.27 Million | CN¥55.24 Million | ▼ -16.4% |
| 2018 | 0.33x | CN¥147.68 Million | CN¥48.51 Million | ▼ -26.2% |
| 2017 | 0.45x | CN¥133.46 Million | CN¥59.43 Million | — |